SCHEMBL17027554

SCHEMBL17027554

CC1C=CCC(C)(C)C1C(=O)CC(C)C(C(=O)OCc1ccccc1)C(=O)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A3 Q01959 1/20 0.34
CTSB P07858 1/20 0.33
CYP3A4 P08684 9/20 0.33
TSHR P16473 8/20 0.33
ALDH1A1 P00352 8/20 0.33
CYP2C9 P11712 6/20 0.33
CYP2C19 P33261 5/20 0.33
LMNA P02545 2/20 0.33
MEN1 O00255 2/20 0.33
CYP1A2 P05177 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
MAPK1 P28482 3/20 0.32
HSD17B10 Q99714 1/20 0.32
SLC15A1 P46059 1/20 0.32
HTR2C P28335 1/20 0.32
CYP2D6 P10635 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17036604 0.90 ALDH1A1 (0.37) KMT2ATDP1ALDH1A1LMNAMEN1
SCHEMBL18815541 0.89 KMT2A (0.36) KMT2ATDP1CYP3A4TSHRALDH1A1
SCHEMBL17036337 0.89 LMNA (0.36) ALDH1A1LMNASMN1; SMN2
SCHEMBL17027579 0.86 LMNA (0.34) CYP3A4TSHRALDH1A1LMNASMN1; SMN2
SCHEMBL19996620 0.84
SCHEMBL14227660 0.82 HSP90AA1 (0.34) KMT2ACYP3A4TSHRALDH1A1CYP2C19
SCHEMBL18255354 0.80 PGR (0.33) SLC6A2SLC6A3
SCHEMBL18817800 0.80 KDM4E (0.32) KMT2A
SCHEMBL18814052 0.77 CTSB (0.34) KMT2ATDP1SLC6A2SLC6A3CTSB
SCHEMBL18815535 0.77 PPARG (0.35) CYP3A4TSHRALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180327695-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2018-11-15 US disclosed
EP-3110393-B1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO KGAA (DE) 2018-10-31 EP disclosed
EP-3368504-A1 PHOTOLABILE PRO-FRAGRANCES Henkel AG & Co. KGaA (DE) 2018-09-05 EP disclosed
US-9926258-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2018-03-27 US disclosed
US-9926258-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2018-03-27 US disclosed
US-9926258-B2 Photolabile pro-fragrances HENKEL AG & CO. KGAA (DE) 2018-03-27 US disclosed
WO-2017071874-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2017-05-04 WO disclosed
WO-2017071874-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2017-05-04 WO disclosed
EP-3110393-A1 PHOTOLABILE PRO-FRAGRANCES Henkel AG & Co. KGaA (DE) 2017-01-04 EP disclosed
US-20160347704-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2016-12-01 US disclosed
US-20160347704-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2016-12-01 US disclosed
US-20160347704-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2016-12-01 US disclosed
WO-2015124671-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2015-08-27 WO disclosed
WO-2015124671-A1 PHOTOLABILE PRO-FRAGRANCES HENKEL AG & CO. KGAA (DE) 2015-08-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160347704-A1 PHOTOLABILE PRO-FRAGRANCES CUTA, FAAH, FAAH2 KMT2A 977/4885TDP1 3111/4885SLC6A2 4850/4885
US-20180327695-A1 PHOTOLABILE PRO-FRAGRANCES CUTA, CRY1, LAGE3 KMT2A 2087/4885TDP1 2437/4885SLC6A2 4882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.